Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Allopurinol-Imp-F | 321571-07-7 |
(Ethyl-(E/Z)-3-(2-Carbethoxy-2-Cynoethenyl)Amino-1h-Pyrozole-4-Carboxylate) |
EP: F |
|
Allopurinol-Imp-E | 31055-19-3 |
(Ethyl 5-(Formylamino)-1h-Pyrazole-4-Carboxylate) |
EP: E |
|
Allopurinol-Imp-D | 6994-25-8 |
(Ethyl 5-Amino-1h-Pyrazole-4-Carboxylate) |
EP: D |
|
Allopurinol-Imp-C | 1346604-13-4 |
(4h-1,2,,4-Triazole-4-Yl)-1h-Pyrazole-4-Carboxamide |
||
Allopurinol-Imp-B | 22407-20-1 |
(5-(Formylamino)-1h-Pyrazole-4-Carboxamide) |
||
Allopurinol API | 315-30-0 |
1H-Pyrazolo[3,4-d]pyrimidin-4-ol |
API |
|
27511-79-1 |
5-Amino-1h-Pyrazole-4-CarboxylicAmide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Atenolol-Imp-G | 56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
|
Atenolol Imp – I | 1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
|
Atenolol-Imp-F | 87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
|
Atenolol-Imp-E | 141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
|
Atenolol-Imp-D | 115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
|
Atenolol-Imp-C | 29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
|
Atenolol Imp – B | 61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
|
Atenolol-Imp-A | 17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
|
ATENOLOL | 17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
||
1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
||
87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
||
141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
||
115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
||
29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
||
61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
||
17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
||
17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Acetaminophen-D3 | Acetaminophen-D3 |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Aripiprazole-D8 | (7-[4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl-D8]Butoxy]-3,4-Dihydrocarbostyril) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
AcetylsalicylicAcid EP Impurity F (Aspirin Impurity F) | 1466-82-6 |
acetylsalicylicanhydride |
EP-F |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Adefovir-D4 | (P-[[2-(6-Amino-9H-Purin-9-Yl-D4)Ethoxy]Methyl]PhosphonicAcid) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Amlodipine-D4Maleic Acid Salt | Amlodipine-D4 Maleic Acid Salt |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Atenolol-Imp-G | 56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
|
Atenolol Imp – I | 1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
|
Atenolol-Imp-F | 87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
|
Atenolol-Imp-E | 141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
|
Atenolol-Imp-D | 115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
|
Atenolol-Imp-C | 29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
|
Atenolol Imp – B | 61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
|
Atenolol-Imp-A | 17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
|
ATENOLOL | 17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Atenolol-Imp-G | 56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
|
Atenolol Imp – I | 1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
|
Atenolol-Imp-F | 87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
|
Atenolol-Imp-E | 141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
|
Atenolol-Imp-D | 115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
|
Atenolol-Imp-C | 29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
|
Atenolol Imp – B | 61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
|
Atenolol-Imp-A | 17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
|
ATENOLOL | 17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Atenolol-Imp-G | 56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
|
Atenolol Imp – I | 1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
|
Atenolol-Imp-F | 87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
|
Atenolol-Imp-E | 141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
|
Atenolol-Imp-D | 115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
|
Atenolol-Imp-C | 29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
|
Atenolol Imp – B | 61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
|
Atenolol-Imp-A | 17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
|
ATENOLOL | 17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Atenolol-Imp-G | 56392-14-4 |
2-[4-[(2rs)-2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]Phenyl]Acetic Acid |
EP: G |
|
Atenolol Imp – I | 1797116-92-7 |
Atenolol Ethylamino Analog Or 2-(4-(3-(Ethylamino)-2-hydroxypropoxy)phenyl)acetamide |
EP: I |
|
Atenolol-Imp-F | 87619-83-8 |
4,4′-[[(1-Methylethyl)Imino]Bis[(2-Hydroxy-3,1-Propanediyl)Oxy]]Bis-Benzeneacetamide |
EP: F |
|
Atenolol-Imp-E | 141650-31-9 |
4,4′-[(2-Hydroxy-1,3-Propanediyl)Bis(Oxy)]Bis-Benzeneacetamide |
EP: E |
|
Atenolol-Imp-D | 115538-83-5 |
2-[4-[(2rs)-3-Chloro-2-Hydroxypropoxy]Phenyl]Acetamide |
EP: D |
|
Atenolol-Imp-C | 29122-69-8 |
(2-[4-(2,3-Epoxy Propaxy)Phenyl]Acetamide) |
EP: C |
|
Atenolol Imp – B | 61698-76-8 |
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide [Diol] |
EP: B |
|
Atenolol-Imp-A | 17194-82-0 |
2(4-Hydroxyphenyl) Acetamide |
EP: A |
|
ATENOLOL | 17194-82-0 |
2(4-Hydroxyphenyl)Acetamide |
EP:A |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Betahistamine-d3 | Betahistamine-d3-dihydrochloride |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
CyclobenzaprineD3-Hcl | 1184983-42-3 |
(3-(5H-Dibenzo[A,D]Cyclohepten-5-Ylidene)-N-Methyl-N-(Methyl-D3)-1-PropanamineHydrochloride) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Candesartan | 139481-59-7 |
(2-Ethoxy-1-({4-[2-(2H-1,2,3,4-Tetrazol-5-Yl)Phenyl]Phenyl}Methyl)-1H-1,3-Benzodiazole-7-CarboxylicAcid) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
59729-33-8 |
Citalopram HBR |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Clopidogrel-EthylAnalogue Hdrochloride salt |
N/A |
|||
113665-84-2 |
ClopidogrelAPI |
API |
||
1357474-92-0 |
Clopidogrel-EthylAnalogue sulphate salt |
Ethyl Ester Analog |
CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Dapagliflozin Keto Intermediate(Dapagliflozin Bromo Keto impurity) | 1404477-10-6 |
(5-Bromo-2-chlorophenyl)(2-ethoxyphenyl)methanone |
Intermediate(Imp) |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Desloratidine | 100643-17-8 |
Desloratidine API |
API |
|
Desloratadine Formyl Impurity | 117810-61-4 |
8-Chloro-6,11-dihydro-11-(1-formyl-4-piperidin ylidene)-5H-benzo[5,6]cyclohepta[1,2-b] pyridine |
Formyl |
|
Desloratidine-Methyl Impurity | 38092-89-6 |
8-Chloro Azatidine (N-Methyl Loratidine) |
Methyl |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Diclofenac Impurity B | 22121-58-0 |
: 2-[(2,6-Dichlorophenyl)amino]benzaldehyde |
Imp – B |
|
Diclofenac Impurity C | 27204-57-5 |
[2-[(2,6-Dichlorophenyl) amino] phenyl] methanol |
Imp – C |
|
Diclofenac Carboxylic Acid | 13625-57-5 |
2-[(2,6-Dichlorophenyl)amino]benzoic acid |
Acid |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Darunavir-D9 | [(4R)-2,3,3a,4,5,6a-Hexahydrofuro[2,3-B]Furan-4-Yl] N-[(2S,3R)-4-[(4-Aminophenyl)Sulfonyl-[1,1,2,3,3,3-Hexadeuterio-2-(Trideuteriomethyl)Propyl]Amino] -3-Hydroxy-1-Phenylbutan-2-Yl]Carbamate |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Dabigatran intermediate | 211919-84-3 |
1-methyl-2-[N-(4-Cyanophenyl)aminomethyl]benzimadazole-5-yl-carboxilic acid-N-(2-pyridyl)-N-(2-Ethoxy carbonyl ethyl)amide |
N/A |
|
Dabigatran intermediate | 103041-38-9 |
Ethyl 3-(pyridin-2-ylamino) propanoate |
N/A |
|
Dabigatran intermediate | 42288-26-6 |
2-(4-Cyanophenylamino)acetic acid |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Dolutegravir Intermediate | R-3-aminobutanol |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
DAS-Des hydroxy Ethyl Impurity | 910297-51-7 |
N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl] amino]-5-thiazolecarboxamide |
Imp |
|
Dasatinib Carboxylic Acid Ethyl Ester | 910297-62-0 |
4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic acid ethyl ester |
Acid |
|
Dasatinib Carboxylic Acid | 910297-53-9 |
4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic acid |
Acid |
|
Dasatinib N-Oxide | 910297-52-8 |
N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide |
||
Dasatinib API | 302962-49-8 |
N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide |
N/A |
|
Dasatinib Intermediate | 302964-24-5 |
2-Amino-N-[2-Chloro-6-Methylphenyl]Thiazole-5-Carboxamide |
N/A |
|
Dasatinib Dichloro Impurity | 302964-08-5 |
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide |
Imp |
|
Dasatinib Related Compound | 2-Amino-thiazole-5-carboxylic acid o-tolylamide |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Enalaprilate or Enalapril Imp-C | 76420-72-9 |
(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
EP-C |
|
Enalapril Imp – B | 82717-96-2 |
ECPP Alanine |
EP-B |
|
Enalapril | 76095-16-4 |
Enalapril maleate EP |
Maleate |
|
Enalapril-Imp-D | 115729-52-7 |
(2-[1,4-Dioxo-3-Methylocta hydro pyrrolo[1,2-A]Pyrazine-2-Yl]-4-Phenylbutyric Acid Ethyl Ester) |
EP-D |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Edaravone | 56-17-7 |
Cystamine dihydrochloride |
N/A |
|
Edaravone | 89-25-8 |
3-Methyl-1-Phenyl-1H-Pyrazole-5(4H)-One |
N/A |
|
Entacapone –E- Isomer | 130929-57-6 |
( 2-Cyano-N,N-Diethyl-3-(3,4-Dihydroxy-5-Nitrophenyl) Propenamide) |
E-Isomer |
|
Entacapone Z-Isomer (IMP-A) | 145195-63-7 |
(2Z)-2-Cyano-3-(3,4-Dihydroxy-5-Nitrophenyl)-N,N-Diethyl-2-Propenamide |
EP-A |
|
Entacapone-Imp-C | 116313-85-0 |
3,4-Dihydroxy-5-Nitro-Benzaldehyde |
EP-C |
|
Entacapone-Imp-H | 115310-15-8 |
Entacapone Piperidine Analogue |
EP-H |
|
Entacapone-Imp-G | 857629-78-8 |
Entacapone (Methoxy Impurity) (2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide) |
EP-G |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Etravirine Intermediate | 329187-59-9 |
4-(4,6-Dichloropyrimidine-2-yl-amino)benzonitrile |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Ezogobine | N/A |
Ezogobine -di-acetyl Impurity |
Di-Acetyl |
|
Ezogobine related compound-4 | N/A |
[4-(4-Fluoro-benzylamino)-2-nitro-phenyl]-carbamic acid ethyl ester |
RC-4 |
|
Ezogobine related compound-3 | N/A |
Acetylamino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester |
RC-3 |
|
Ezogobine related compound-2 | N/A |
(2-Amino-4-benzylamino-phenyl)-carbamic acid ethyl ester |
RC-2 |
|
Ezogobine related compound-1 | N/A |
(2,4-Diamino-phenyl)-carbamic acid ethyl ester |
RC-1 |
|
Ezogabine | 150812-12-7 |
Ezogabine API |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Ezogobine | N/A |
Ezogobine -di-acetyl Impurity |
Di-Acetyl |
|
Ezogobine related compound-4 | N/A |
[4-(4-Fluoro-benzylamino)-2-nitro-phenyl]-carbamic acid ethyl ester |
RC-4 |
|
Ezogobine related compound-3 | N/A |
Acetylamino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester |
RC-3 |
|
Ezogobine related compound-2 | N/A |
(2-Amino-4-benzylamino-phenyl)-carbamic acid ethyl ester |
RC-2 |
|
Ezogobine related compound-1 | N/A |
(2,4-Diamino-phenyl)-carbamic acid ethyl ester |
RC-1 |
|
Ezogabine | 150812-12-7 |
Ezogabine API |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Ezogobine | N/A |
Ezogobine -di-acetyl Impurity |
Di-Acetyl |
|
Ezogobine related compound-4 | N/A |
[4-(4-Fluoro-benzylamino)-2-nitro-phenyl]-carbamic acid ethyl ester |
RC-4 |
|
Ezogobine related compound-3 | N/A |
Acetylamino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester |
RC-3 |
|
Ezogobine related compound-2 | N/A |
(2-Amino-4-benzylamino-phenyl)-carbamic acid ethyl ester |
RC-2 |
|
Ezogobine related compound-1 | N/A |
(2,4-Diamino-phenyl)-carbamic acid ethyl ester |
RC-1 |
|
Ezogabine | 150812-12-7 |
Ezogabine API |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Furazolidone | 67-45-8 |
(3-{[(5-Nitro-2-Furyl)Methylene]Amino}-1,3-Oxazolidin-2-One) |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Fenbufen | Fenbufen |
4-(4-Biphenylyl)-4-OxobutanoicAcid |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Ketoconazole | 65277-45-1 |
Ketoconazole USP 30 |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Lansoprazole | Nitro Sulfoxide |
N/A |
||
Lansoprazole-D4 | (2-[[[3-Methyl-4-(2,2,2-Trifluoro ethoxy)-2-Pyridinyl]Methyl] Sulfinyl]-1H-Benzimidazole-D4) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Letrozole Intermediate | 4-[1,2,4]Triazol-1-ylmethyl-benzonitrile |
N/A |
||
Letrozole Intermediate | N/a |
1,3,4(Isomer)1,3,4 Trizole |
N/A |
|
Letrozole-Imp-C | N/A |
4[1,3,4]Triazol-1-Ylmethyl-Benzonitrile |
EP-C |
|
Letrozole-Imp-B | 113402-31-6 |
4,4′,4″-Methanetriyltribenzonitrile |
EP-B |
|
Letrozole-Imp-A (Iso-Letrozole) | 112809-52-6 |
4,4-(4H-1,3,4-Triazol-4-Ylmethylene)Bisbenzonitrile; |
EP-A |
|
Letrozole | 112809-51-5 |
(4,4′-(1H-1,2,4-Triazol-1-Ylmethylene)Dibenzonitrile) |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Levothyroxine-T6 Imp | 911661-90-0 |
O-(4-Hydroxy-3,5-Diiodophenyl)Thyroxine |
N/A |
|
Levothyroxine N-Acetyl or Levothyroxine N-Acetyl T4 | 26041-51-0 |
2-acetamido 3-(4-(4-hydroxy-3,5 diiod phenoxy)-3,5 diiodophenyl)propanoic acid |
N-Acetyl |
|
Levothyroxine | 18835-59-1 |
3,5-Diiodo-L-tyrosine dihydrate |
N/A |
|
Levothyroxine N-Methylamide | 2088032-52-2 |
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)- 3,5-diiodophenyl]-N-methylpropanamide |
Impurity |
|
N-Formyl Levothyroxine | 671235-41-9 |
N-Formyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine |
Impurity |
|
Levothyroxine T3 ( Free base ) | 2-Amino-3-[3-(4-hydroxy-3-iodo-phenoxy)-2,4-diiodo-phenyl]-propionic acid |
N/A |
||
Liothyronine Sodium Salt (Levothyroxine T3) | 55-06-1 |
sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate |
API |
|
Levothyroxine T6 Compound ( Levothyroxine Imp F) | 911661-90-0 |
(2S)-2-Amino-3-[4-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenoxy]-3,5-diiodophenyl]propanoic acid |
Imp F |
|
Levothyroxine Acetic Acid Imp | Levothyroxine Acetic Acid Imp |
N/A |
||
Levothyroxine | 21959-36-4 |
ethyl 2-acetamido-3-(4-hydroxy-3,5-diiodophenyl) propionate |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Linezolid related compound | (S)-(−)-Oxirane-2-methanol butyrate |
RC |
||
Linezolid related compound | 60456-26-0 |
(R)-(−)-Oxirane-2-methanol butyrate |
RC |
|
Linezolid related compound | 1798887-61-2® |
2-[4-(3-Fluoro-4-morpholin-4-yl-phenylamino)-3-hydroxy-butyl]-isoindole-1,3-dione(RECIMIC) |
RC |
|
Linezolid related compound | 947736-16-5(R)168828-89-5(S) |
2-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-isoindole-1,3-dione(R,S) |
RC |
|
Linezolid Intermediate | 174649-09-3 |
(5R)-3-[3-Fluoro-4-(4-Morpholinyl)Phenyl]-5-[[(Methylsulfonyl)Oxy]Methyl]-2-Oxazolidinone |
RC D |
|
Linezolid Intermediate | 858344-36-2 |
3-[3-fluoro-4-(4-morpholinyl)phenyl]-5- |
RC D |
|
Linezolid N-Oxide(Hygroscopic) | 189038-36-6 |
(S)-N-[[3-[3-Fluoro-4-(4-oxido-4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide |
N-Oxide |
|
Linezolid | 174649-09-3 |
(R)-N-(3-(3-fluoro-(4-morpholinyl)phenyl-2-oxo-5-oxazolidinyl)methanol meSylate |
RC D |
|
Des-Fluoro Linezolid | 556801-15-1 |
Des-Fluoro Linezolid;(N-[[(5s)-3-[4-(4-Morpholinyl)Phenyl]-2-Oxo-5-Oxazolidinyl] Methyl] Acetamide) |
Des-Fluoro |
|
Linezolid N,O-Descarbonyl | 333753-67- 6 |
N-[3-(3-Fluoro-4-morpholin-4-yl-phenylamino)-2-hydroxy-propyl]-acetamide |
N,O Des |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Lenalidomide-Intermediate | N/A |
Lenalidomide Boc –Cyclised glutamine |
N/A |
|
Lenalidomide-Intermediate | N/A |
Lenalidomide Compound or Methyl-2Methyl-3 Nitro benzate |
N/A |
|
Lenalidomide | N/A |
N-Acetyl Lenalidomide |
N-Acetyl |
|
Lenalidomide-Related Compound | N/A |
Lenalidomide N-Methyl Impuirty |
N-Methyl |
|
Lenalidomide-Related Compound | N/A |
Lenalidomide N-Formyl Impuirty |
N-Formyl |
|
Lenalidomide-Related Compound | N/A |
2-(4-amino-1,3-dihydro-1-oxo-2H-isindol-2-yl)glutaric acid sodium salt |
RC |
|
Lenalidomide-Related Compound | 827026-45-9 |
Lenalidomide Nitro Impurity 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |
RC |
|
Lenalidomide-Related Compound | N/A |
Lenalidomide Di acid Impurity )2-(4-amino-1,3-dihydro-1-oxo-2H-isindol-2-yl)glutaric acid Potassium salt) |
RC |
|
Lenolidomide-API | 191732-72-6 |
(3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione) |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Lactone | Lactone |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Mycophenolate Mofetil-Di | Morpholine Ethanol Analogue Or Mycophenolate modetil morpholinoethyl ethern |
Mofetil-Di |
||
Mycophenolic acid sorbitol ester | N/A |
6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-isobenzofuran-5-yl)-4-methyl-hex-4-enoic acid 2,3,4,5,6-pentahydroxy-hexyl ester |
N/A |
|
Mycophenolate | N/A |
2-chloromethyl)4,6-dimethoxy benzaldehyde |
N/A |
|
Mycophenolate Mofetil-N-Oxide | 224052-51-1 |
Mycophenolate Mofetil-N-Oxide Imp-G |
N-oxide |
|
Mycophenolate (EP Impurity E) | 31858-66-9 |
Mycophenolate acid Methyl Ester |
Methyl ester |
|
Mycophenolate Mofetil RC A (O-Desmethyl Mycophenolate Mofetil ) | 1322681-36-6 |
2-Morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
RC A |
|
Mycophenolate Mofetil | 128794-94-5 |
Mycophenolate mofetil ( API) |
API |
|
Mycophenolic acid | 24280-93-1 |
Mycophenolic acid |
Acid |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Megestrol Acetate | 595-33-5 |
(17-(Acetyloxy)-6-Methylpregna-4,6-Diene-3,20-Dione) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Metformin-D6-Hcl | 1185166-01-1 |
(N,N-Dimethylimidodicarbonimidic Diamide-D6, Hydrochloride) |
||
Metformin EP Impurity E | 36801-25-9 |
N-Desmethyl Metformin Sulfate |
Imp E |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Mesalamine | N-acetyl Mesalamine (5-acetylamino-2-hydroxybenzoic acid) |
N/A |
||
Mesalamine | N-propyl Mesalamine |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Metoprolol Methoxy Epoxide Impurity | 56718-70-8 |
1-[2-(2-Methoxyethyl)phenyoxy]-2,3-epoxypropane |
Epoxide |
|
Metoprolol Hydroxy Epoxide Impurity | 104857-48-9 |
1-[2-(2-Hydroxyethyl)phenyoxy]-2,3-epoxypropane |
Hydroxy Epoxide |
|
Metoprolol Bis propanol(BPP) | 230975-30-1 |
1,3-bis[4-(2-Methoxyethyl) phenoxy]propan-2-ol |
BPP |
|
Metoprolol Impurity –O/ USP RC D | 154784-36-8 |
1,1’-[(1-Methylethyl)Imino]Bis[3-[4-(2-Methoxyethyl)Phenoxy]-Propan-2-Ol] |
EP-O |
|
Metoprolol Impurity –N | 6452-57-9 |
(2rs)-3-[(1-Methylethyl)Amino]-Propane-1,2-Diol |
EP-N |
|
Metoprolol Impurity –M | 73313-36-7 |
1,3-Bis[(1-Methylethyl)Amino]-Propan-2-Ol |
EP-M |
|
Metoprolol Impurity –J | 163685-37-8 |
1-[2-Hydroxy-3-[(1-Methylethyl)Amino]Propoxy]-3-[4-(2-Methoxyethyl)Phenoxy]Propan-2-Ol |
EP-J |
|
Metoprolol EP Impurity –H | 62572-94-5 |
(2rs)-1-[4-(2-Hydroxyethyl)Phenoxy]-3-[(1- Methylethyl)Amino]Propan-2-Ol |
EP-H |
|
72570-70-8 |
( 4-(2-Hydroxy-3-Isopropylaminopropoxy)Benzoic Acid |
Acid |
||
Metoprolol EP Impurity-F | 7695-63-8 |
2rs)-1-[(1-Methylethyl)Amino]-3-Phenoxypropan-2-Ol |
EP-F |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Misoprostol API | 59122-46-2 |
Methyl 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-4-Hydroxy-4-methylocr-1-enyl)-5-oxocyclopentyl)heptanoate |
API |
|
Misoprostol EP impurity D | Misoprostol EP impurity D |
EP-D |
||
Misoprostol EP impurity C | Misoprostol EP impurity C |
EP-C |
||
HPMC | hydroxypropylmethylcellulose |
|||
Misoprostol 1% HPMC | Misoprostol 1% HPMC Bulk Dispersion(Standard) |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Montelukast | 151767-02-1 |
Montelukast (sodium salt) |
||
Montelukast | 158966-92-8 |
Montelukast Free Base |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Nimesulide Impurity-F | 51765-72-1 |
N,N-Bis(Methylsulphonyl)-4-Nitro-2-Phenoxyaniline |
EP-F |
|
Nimesulide Impurity-D | 5422-92-4 |
4-Nitro-2-Phenoxyaniline |
EP-D |
|
Nimesulide Impurity-A | 51765-56-1 |
N-(2,4-Dinitro-6-Phenoxyphenyl) Methanesulphonamide |
EP-A |
|
Nitrofurantoin Related Compound A | 63981-22-6 |
3-(5-Nitrofurfurylideneamino)hydantoic Acid |
USP |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
N-desmethyl Sertraline | Desmethyl Sertraline |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Desmethyl Naproxen | Desmethyl Naproxen |
|||
Naproxen-API | Naproxen-API |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Nitrasomethylurea | 684-93-5 |
Nitrasomethylurea |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Megestrol Acetate | 595-33-5 |
(17-(Acetyloxy)-6-Methylpregna-4,6-Diene-3,20-Dione) |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Omeprazole | 88546-55-8 |
Omeprazole Sulfone |
Sulfone |
|
Omeprazole Sulfide( Imp C (Ep) | 73590-85-9 |
Omeprazole Sulfide |
EP-C |
|
Esomeprazole Sulphone | 88546-55-8 |
Esomeprazole Sulphone |
Eso |
|
Omeprazole-Ep-Imp-E | 176219-04-8 |
Omeprazole –N-Oxide |
EP-E |
|
Omeprazole-Ep-Imp-I | 158812-85-2 |
Omeprazole Sulphone-N-Oxide |
EP-I |
|
Omeprazole | Omeprazole API |
API |
||
Omeprazole | 863029-89-4 |
Chloro Omeprazole |
Chloro |
|
Esomeprazole | 119141-88-7 |
(S)-(−)-5-Methoxy-2-[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methylsulfinyl]-3H-Benzoimidazole |
||
Omeprazole | 88546-55-8 |
Omeprazole Sulfone |
Sulfone |
|
Omeprazole Sulfide( Imp C (Ep) | 73590-85-9 |
Omeprazole Sulfide |
EP-C |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Oxcarbazepine Imp-B | 28721-09-7 |
10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide; 10-Methoxycarbamazepine |
IMP-B |
|
Oxcarbamazepine Or Carbamazepine | 28721-07-5 |
Carbamazapine-API |
API |
|
Trityl protected Olmesartan | 144690-92-6 |
Trityl protected Olmesartan |
Imp |
|
Olmesartan Ep-Imp-A | 144689-24-7 |
Olmesartan (Acid Impurity) |
EP-A |
|
Olmesartan Intermediate | 144689-93-0 |
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1H-Imidazole-5-Carboxylate (HMPIC) |
||
Olmesartan modexmil API | (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate |
API |
||
Trityl protected Olmesartan | 144690-92-6 |
Trityl protected Olmesartan |
Imp |
|
Olmesartan Ep-Imp-A | 144689-24-7 |
Olmesartan (Acid Impurity) |
EP-A |
|
Olmesartan Intermediate | 144689-93-0 |
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1H-Imidazole-5-Carboxylate (HMPIC) |
||
Olmesartan modexmil API | (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Oxcarbamazepine Imp-K | 1346601-76-0 |
Oxcarbamazepine N- formyl impurity |
IMP-K |
|
Oxcarbamazepine related compound Or Dehydro Eslicarbazepine Acetate | 952740-00-0 |
Oxcarbamazepine related compound (Enol Acetate ) |
N/A |
|
Eslicarbazepine Acetate | 236395-14-5 |
(S)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
N/A |
|
Oxcarbazepine | 13080-75-6 |
5-Acetyl-10,11-dihydro-5H-dibenzo[b,f]azepine |
N/A |
|
Oxcarbazepine | N/A |
1-(10-Hydroxy-4a,10,11,11a-tetrahydro- |
N-Acetyl |
|
Oxcarbazepine | N/A |
Acetic acid 5-acetyl-5a,9a,10,11-tetrahydro-5H-dibenzo[b,f]azepin-10-yl ester N-Acetyl SLB |
N-Acetyl |
|
Oxcarbamazepine | 104746-03-4 |
R-licarbazepine |
N/A |
|
Oxcarbamazepine/ Eslicarbazepine | 29331-92-8 |
(10,11-Dihydro-10-Hydroxy-5H-Dibenz[B,F]Azepine-5-Carboxamide) or ( Recimic Hydroxy oxcarbamazepine) |
N/A |
|
Oxcarbamazepine Eslicarbazepine | 104746-04- 5 |
S- licarbazepine |
N/A |
|
Oxcarbazepine Imp – I (11-Keto Oxcarbazepine) | 537693-29-1 |
10,11-Dihydro-10,11-dioxo CarbaMazepine |
IMP-I |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Olanzapine Related Compound | 138564-58-6 |
2-Amino-5-Methyl-3-Thiophenecarbonitrile |
N/A |
|
Olanzapine | 138564-61-1 |
1-[[2-[(2-Aminophenyl)Amino]-5-Methyl-3-Thienyl]Carbonyl]-4-Methyl-Piperazine |
N/A |
|
Olanzapine Lactam ImpUSP B/ BP B | 221176-49-4 |
2-Methyl-10h-Thieno-[2,3-B][1,5]Benzodiazepin-4[5h]-One |
USP B |
|
N-Desmethyl Olanzapine | 161696-76-0 |
(2-Methyl-4-(1-Piperazinyl)-10H-Thieno[2,3-B][1,5]Benzodiazepine) |
N-Desmthyl |
|
Olanzapine-Imp-A | 138564-59-7 |
(5-Methyl-2-((2-Nitrophenyl)Amino)-3-Thiophenecarbonitrile) |
EP-A |
|
Olanzapine API | 132539-06-1 |
Olan (2-Methyl-4-(4-Methyl-1-Piperazinyl)-10H-Thieno[2,3-B][1,5]Benzodiazepine) |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Oxybutynin | N/A |
4-(dimethylamino)but-2-yn-1-yl 2 –cyclohexyl-2-((4- (dimethylamino) but-2-yn-1-yl)oxo)-2-phenyl acetate |
Imp-3 |
|
Oxybutynin API | 5633-20-5 |
4-Diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylethanoate |
API |
|
Oxybutynin | 4-(dimethylamino)but-2-yn-1-yl 2 –cyclohexyl-2-((4- (dimethylamino) but-2-yn-1-yl)oxo)-2-phenyl acetate |
Imp-3 |
||
Oxybutynin API | 5633-20-5 |
4-Diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylethanoate |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Omeprazole | 110374-16-8 |
Desmethoxy Omeprazole |
Desmethoxy |
|
ORNIDAZOLE API | 16773-42-5 |
1-(3-chloro-2-hydroxypropyl-2-methyl -4- nitroimidazole |
API |
|
ORNIDAZOLE | 16773-52-7 |
1-(2,3-epoxypropyl)-2-methyl -5- nitroimidazole |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Pregbalin API | 148553-50-8 |
Pregbalin API |
API |
|
Pregbalin Amide ester | N/A |
3-Carbamoylmethyl-5-methyl-hexanoic acid methyl ester |
Amide ester |
|
Pregbalin | 181289-15-6 |
(±)-3-(Carbamoymethyl)-5-methylhexanoic acid |
N/A |
|
Pregbalin Imp-B | 75143-89-4 |
3-Isobutylglutaric Acid Or Diacid Imp |
EP-B |
|
(S)-Pregbaline lactum | 181289-23-6 |
2-Pyrrolidinone,4-(2-Methylpropyl) Or 4-Isobutylpyrrolidin-2-One Or Lactum Impurity |
Lactum |
|
Pregabalin Lactum imp USP RC C | 61312-87-6 |
(4-Isobutyl-Pyrrolidin-2-One) |
USP RC C |
|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Pioglitazone Intermediate | 2295-31-0 |
2,4-thiazolidinedione |
N/A |
|
Pioglitazone | 145350-09-0 |
Pioglitazone-N-Oxide |
N-oxide |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Tolvaptine | methyl-5-Bromo-2-(N-p-Tolune Sulfonyl)amino benzoate |
N/A |
||
Tolvaptine Bromo Impurity | 219786-43-8 |
7-Bromo-1, 2, 3, 4-Tetrahydro Benzo[B]Azepine-5-One |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Temozolamide acid Imp | 113942-30-6 |
Temozolamide acid Imp |
Acid |
|
Temozolomide | 85622-93-1 |
Temozolomide |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Timolol-Imp-I | N/A |
(2rs)-1-(Ethylamino)-3-[[4-(Morpholin-4-Yl)-1,2,5-Thiadiazol-3-Yl]Oxy]Propan-2-Ol ; |
EP-I |
|
Timolol-Imp-G | 75202-36-7 |
Timolol S-Oxide(enol form) |
EP-G |
|
Timolol-Imp-G | 75202-36-7 |
Timolol -S-Oxide (keto form) |
EP-G |
|
Timolol-Imp-D | 30165-97-0 |
(4-(Morpholin-4-Yl)-1,2,5-Thiadiazol-3-Ol) |
EP-D |
|
Timolol-Imp-B (Iso-Timolol) | 59697-06-2 |
(2rs)-3-[(1,1-Dimethylethyl)Amino ] -2-[[4-(Morpholin-4-Yl)-1,2,5-Thiadiazol-3-Yl]Oxy]Propan-1-Ol ; |
EP-B |
|
Timolol Maleate | 26921-17-5 |
(-)-1-(Tert-Butylamino)-3-((4-Morpholino-1,2,5-Thiadiazol-3-Yl)Oxy)-2-Propanol Maleate |
Maleate |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Tramadol-D6 | Tramadol-D6-Hydrochloride |
EP-C |
||
Tramadol –Imp -B | 66170-32-9 |
1,2 Olefin: 1-(3-Methoxyphenyl)-2-(dimethylaminomethyl) cyclohex-6-ene hydrochloride |
EP-B |
|
Tramadol Related Compound | 80456-81-1 |
O-Desmethyl Tramadol |
||
Tramadol | 36282-47-0 |
Tramadol API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Terbutaline |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Terbutaline |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
O-desmethyl -Venlafaxine D10 | 1062607-49-1 |
O-Desmethyl Venlafaxine-D 10 |
N/A |
|
Venlafaxine –D10 | Venlafaxine-D10 Hcl; |
N/A |
||
O-Desmethyl-N,N-Didesmethyl Venlafaxine Hcl | Venlafaxine-D10 Hcl; |
N/A |
||
Venlafaxine Imp -D | 93413-90-2 |
N-Desmethyl Venlafaxine |
EP-D / USP RC -A |
|
Venlafaxine Imp-C | 130198-05-9 |
N,N-Didesmethyl Venlafaxine Hydrochloride or (1-[2-Amino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol; hydrochloride |
Imp- C |
|
Venlafaxine Imp-F | 93413-79-7 |
Venlafaxine Imp-F |
EP-F |
|
Venlafaxine Imp-E | 93413-56-0 |
(5-(4-Methoxyphenyl)-3-Methyl-1-Oxa-3-Azaspiro[5.5] Undecane Hydrochloride ) |
EP-E |
|
Venlafaxine-Imp-G | 1076199-92-2 |
Des-hydroxy Venlafaxine |
EP-G |
|
O-Desmethyl Venlafaxine | 93413-62-8 |
4-[2-(Dimethylamino)-1-(1-Hydroxycyclohexyl)Ethyl]Phenol |
N/A |
|
Venlafaxine API | 99300-78-4 |
Venlafaxine Hcl |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
D-Valganciclovir HCl | 1393911-57-3 |
Valganciclovir D-Valine |
EP-I |
|
Valganciclovir | Bis-CBZ-L-valine Gancicclovir |
|||
Valganciclovir-D5-Hcl | [2-[(2-Amino-6-Oxo-3H-Purin-9-Yl)Methoxy]-1,1,2,3,3-Pentadeuterio-3-Hydroxypropyl] (2S)-2-Amino-3-Methylbutanoate;Hydrochloride |
N/A |
||
Valganciclovir | 194154-40-0 |
CBZ-mono protected Gancicclovir |
||
Valganciclovir | 194159-22-3 |
CBZ-mono protected Gancicclovir methyl ester |
||
Valganciclovir Imp-E | 88110-89-8 |
2-(RS)-2-[(2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy]-3-hydroxypropyl acetate |
EP-E |
|
Valganciclovir Imp-A | 82410-32-0 |
Guanine |
EP-A |
|
Valganciclovir Imp-B | 73-40-5 |
Guanine |
EP-B |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Vilazodone Hydrochloride | N/A |
Vilazodone Hydrochloride benzyl alcohol monosolvate |
N/A |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Zolmitriptan-N-Oxide | 251451-30-6 |
(S)-N,N-Dimethyl-2-{5-[(2-Oxooxazolidin-4-Yl)Methyl]-1H-Indol-3-Yl}Ethanamine Oxide |
N-oxide |
|
Zolmitriptan-Intermediate) | 69472-61-3 |
2-Acetyl-5-Dimethylamino-Pentanoicacid Ethylester |
||
Zolmitriptan Imp C | N/A |
(1-[2-(Dimethylamino)Ethyl]-6,6a,7,11-Tetrahydrooxazolo[3,4-B]Pyrrolo[2,3-H]Isoquinolin-9(3H)-One) |
RC-C |
|
Zolmitripton(API) | 139264-17-8 |
(4S)-4-({3-[2-(Dimethylamino)Ethyl]-1H-Indol-5-Yl}Methyl)-1,3-Oxazolidin-2-One |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Ziprasidone intermediet | 89691-88-1 |
(-3-(1-Piperazinyl)-1,2-benzisothiazole hydrochloride) |
Product Name | CAS | Name | Structure | Code |
---|
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
Zolpidem-Intermediate | N,N-Dimethyl-1-[6-Methylphenyl)Imidazole[1,2-A]Pyridine-3-Yl]Methaneamine |
|||
Zolpidem Aldehyde/ Zolpidem carbaldhyde | 400777-11-9 |
6-Methyl-2-(4-Methylphenyl)-Imidazo[1,2-A]Pyridine-3-Carboxaldehyde |
N/A |
|
Zolpidem-Intermediate | 189005-44-5 |
2-(6-Methyl-2-P-Tolyl-Imidazo[1,2-A]Pyridin-3-Yl)-Acetic Acid |
||
Zolpidem-Imp-B | 40038-68-8 |
N,N-Dimethyl-2-(6-Methyl-2-P-Tolylimidazo[1,2-A]Pyridin-3-Yl)-2-Oxoacetamide |
EP-C |
|
Zolpidem-Imp-A | 1346600-85-8 |
N,N-Dimethyl-2-[7-Methyl-2-(4-Methylphenyl)Imidazo[1,2-A]Pyridin-3-Yl] methaneamine |
EP-A |
|
Zolpidem | N/A |
Zolpedem Methanol |
||
Zolpidem- API | 82626-48-0 |
(N,N-Dimethyl-2-[6-Methyl-2-(4-Methylphenyl)Imidazo[1,2-A]Pyridin-3-Yl]Acetamide) |
API |
Product Name | CAS | Name | Structure | Code |
---|---|---|---|---|
4-Methoxyphenyl boronic acid | 5720-07-0 |
4-Methoxyphenyl boronic acid |
||
Sofosbuvir Intermediate 5 | 1334513-02-8 |
N-[(S)-(2,3,4,5,6-Pentafluorophenoxy) Phenoxyphosphinyl]-L-alanine 1- methylethyl ester |
© 2018 BesilChem. Powered by Sigmato